FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Barry Greenberg

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

United States

Living Beings

Physiology

Up-Regulation

Anatomy

Co-author Network

Publications

TOP 3
Anthony N DeMaria; Gregory K Feld; Barry H Greenberg; Jennifer Hall; Mark Hlatky; Wilbur Y W Lew; João A C Lima; Alan S Maisel; Sanjiv Narayan; Steven Nissen; David J Sahn; Jeroen J Bax; Ori Ben-Yehuda; Sotirios Tsimikas
Highlights of the Year in JACC 2011.
Mihai Gheorghiade; An Thyssen; Robert Zolynas; Venkatesh K Nadar; Barry H Greenberg; Mandeep Mehra; Xiang Sun; Hong Tian; Alexei N Plotnikov; Paul Burton
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure.
Petra H Wirtz; Laura S Redwine; Suzi Hong; Thomas Rutledge; Joel E Dimsdale; Barry H Greenberg; Paul J Mills
Increases in B-type natriuretic peptide after acute mental stress in heart failure patients are associated with alcohol consumption.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Barry Greenberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Anthony N DeMaria; Gregory K Feld; Barry H Greenberg; Jennifer Hall; Mark Hlatky; Wilbur Y W Lew; João A C Lima; Alan S Maisel; Sanjiv Narayan; Steven Nissen; David J Sahn; Jeroen J Bax; Ori Ben-Yehuda; Sotirios Tsimikas
Highlights of the Year in JACC 2011.
Journal of the American College of Cardiology 2012;59(5):503-37.
2011: Mihai Gheorghiade; An Thyssen; Robert Zolynas; Venkatesh K Nadar; Barry H Greenberg; Mandeep Mehra; Xiang Sun; Hong Tian; Alexei N Plotnikov; Paul Burton
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2011;30(2):218-26.
2010: Petra H Wirtz; Laura S Redwine; Suzi Hong; Thomas Rutledge; Joel E Dimsdale; Barry H Greenberg; Paul J Mills
Increases in B-type natriuretic peptide after acute mental stress in heart failure patients are associated with alcohol consumption.
Journal of studies on alcohol and drugs 2010;71(5):786-94.
2010: Petra H Wirtz; Laura Redwine; Sarah Linke; Suzi Hong; Thomas Rutledge; Barry H Greenberg; Paul J Mills
Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patients.
Brain, behavior, and immunity 2010;24(3):366-9.
2009: Michikado Iwata; Jorge E Silva Enciso; Barry H Greenberg
Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme.
American journal of physiology. Cell physiology 2009;297(5):C1318-29.
2009: Paul J Mills; Joel E Dimsdale; Loki Natarajan; Michael G Ziegler; Alan S Maisel; Barry H Greenberg
Sleep and health-related quality of life in heart failure.
Congestive heart failure (Greenwich, Conn.) 2009;15(5):228-33.
2009: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF).
The American journal of cardiology 2009;104(1):107-15.
2009: James D Flaherty; Joseph Rossi; Gregg C Fonarow; Eduardo Nunez; Wendy Gattis Stough; William T Abraham; Nancy M Albert; Barry H Greenberg; Christopher M O'Connor; Clyde W Yancy; James B Young; Charles J Davidson; Mihai Gheorghiade
Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
American heart journal 2009;157(6):1018-25.
2009: Mihai Gheorghiade; Kirkwood F Adams; John G F Cleland; Gad Cotter; G Michael Felker; Gerasimos Filippatos; Gregg C Fonarow; Barry H Greenberg; Adrian F Hernandez; Sadiya Khan; Michel Komajda; Marvin A Konstam; Peter P Liu; Aldo P Maggioni; Barry M Massie; John J McMurray; Mandeep Mehra; Marco Metra; John O'Connell; Christopher M O'Connor; Peter S Pang; Ileana L Piña; Hani N Sabbah; John R Teerlink; James E Udelson; Clyde W Yancy; Faiez Zannad; Norman Stockbridge
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
American heart journal 2009;157(6):957-70.
2009: Anthony N DeMaria; Ori Ben-Yehuda; Jeroen J Bax; Gregory K Feld; Barry H Greenberg; Wilbur Y W Lew; João A C Lima; Alan S Maisel; Sanjiv Narayan; David J Sahn; Sotirios Tsimikas
Highlights of the Year in JACC 2008.
Journal of the American College of Cardiology 2009;53(4):373-98.
2008: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).
The American journal of cardiology 2008;102(11):1524-9.
2008: Joseph Rossi; James D Flaherty; Gregg C Fonarow; Eduardo Nunez; Wendy Gattis-Stough; William T Abraham; Nancy M Albert; Barry H Greenberg; Christopher M O'Connor; Clyde W Yancy; James B Young; Charles J Davidson; Mihai Gheorghiade
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).
European journal of heart failure 2008;10(12):1215-23.
2008: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Eduardo Nunez; Clyde W Yancy; James B Young
A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF.
European heart journal 2008;29(16):1983-91.
2008: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.
Journal of the American College of Cardiology 2008;52(3):190-9.
2008: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Eduardo Nunez; Clyde W Yancy; James B Young
Day of admission and clinical outcomes for patients hospitalized for heart failure: findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
Circulation. Heart failure 2008;1(1):50-7.
2008: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Karen Pieper; Jie Lena Sun; Clyde W Yancy; James B Young
Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF.
Archives of internal medicine 2008;168(8):847-54.
2008: Guillermo Torre Amione; Stefan D Anker; Robert Bourge; Wilson S Colucci; Barry H Greenberg; Per Hildebrandt; Andre Keren; Michael Motro; Lemuel A Moyé; Jan Erik Otterstad; Craig M Pratt; Piotr Ponikowski; Jean-Lucien Rouleau; François Sestier; Bernhard R Winkelmann; James B Young
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.
Lancet 2008;371(9608):228-36.
2008: James B Young; William T Abraham; Nancy M Albert; Wendy Gattis-Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Lilin She; Jie Lena Sun; Clyde W Yancy; Gregg C Fonarow
Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).
The American journal of cardiology 2008;101(2):223-30.
2008: Xiaowei Zhang; Barry H Greenberg; Randy T Cowling
Improving the titer of recombinant adenovirus by suppressing problematic transgene transcription during packaging.
BioTechniques 2008;44(1):85-9.
2007: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
Journal of cardiac failure 2007;13(9):722-31.
2007: Gregg C Fonarow; Wendy Gattis Stough; William T Abraham; Nancy M Albert; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
Journal of the American College of Cardiology 2007;50(8):768-77.
2007: Barry H Greenberg; William T Abraham; Nancy M Albert; Karen Chiswell; Robert Clare; Wendy Gattis Stough; Mihai Gheorghiade; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young; Gregg C Fonarow
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
American heart journal 2007;154(2):277.e1-8.
2007: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis-Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Karen Pieper; Jie Lena Sun; Clyde W Yancy; James B Young
Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
Archives of internal medicine 2007;167(14):1493-502.
2007: Nancy M Albert; Gregg C Fonarow; William T Abraham; Karen Chiswell; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF.
Journal of cardiac failure 2007;13(3):189-98.
2007: Mihai Gheorghiade; William T Abraham; Nancy M Albert; Wendy Gattis-Stough; Barry H Greenberg; Christopher M O'Connor; Lilin She; Clyde W Yancy; James Young; Gregg C Fonarow
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.
European heart journal 2007;28(8):980-8.
2007: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Karen Pieper; Jie Lena Sun; Clyde W Yancy; James B Young
Association between performance measures and clinical outcomes for patients hospitalized with heart failure.
JAMA : the journal of the American Medical Association 2007;297(1):61-70.
2007: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
American heart journal 2007;153(1):82.e1-11.
2006: Mihai Gheorghiade; William T Abraham; Nancy M Albert; Barry H Greenberg; Christopher M O'Connor; Lilin She; Wendy Gattis Stough; Clyde W Yancy; James B Young; Gregg C Fonarow
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.
JAMA : the journal of the American Medical Association 2006;296(18):2217-26.
2006: Barry H Greenberg; Mandeep Mehra; John R Teerlink; Paul Ordronneau; David McCollum; Edward M Gilbert
COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure.
The American journal of cardiology 2006;98(7A):53L-59L.
2006: Milton Packer; Mary Ann Lukas; David M Tenero; Charlotte A Baidoo; Barry H Greenberg
Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
The American journal of cardiology 2006;98(7A):39L-45L.
2006: Milton Packer; William T Abraham; Mandeep Mehra; Clyde W Yancy; Christine E Lawless; Judith E Mitchell; Frank W Smart; Rachel Bijou; Christopher M O'Connor; Barrie Massie; Ileana Pina; Barry H Greenberg; James B Young; Daniel P Fishbein; Paul J Hauptman; Robert Bourge; John E Strobeck; Srinvivas Murali; Douglas Schocken; John R Teerlink; Wayne C Levy; Robin J Trupp; Marc A Silver
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure.
Journal of the American College of Cardiology 2006;47(11):2245-52.
2005: Michikado Iwata; Randy T Cowling; Devorah Gurantz; Cristina Moore; Shen Zhang; Jason X-J Yuan; Barry H Greenberg
Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects.
American journal of physiology. Heart and circulatory physiology 2005;289(6):H2356-63.
2005: Randy T Cowling; Xiaowei Zhang; Vanessa C Reese; Michikado Iwata; Devorah Gurantz; Wolfgang H Dillmann; Barry H Greenberg
Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts.
American journal of physiology. Heart and circulatory physiology 2005;289(3):H1176-83.
2005: Devorah Gurantz; Arne Yndestad; Bente Halvorsen; Ottar V Lunde; Jeffrey H Omens; Thor Ueland; Pål Aukrust; Cristina D Moore; John Kjekshus; Barry H Greenberg
Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling.
Cardiovascular research 2005;67(1):106-15.
2005: Devorah Gurantz; Randy T Cowling; Nissi M Varki; Eduardo Frikovsky; Cristina D Moore; Barry H Greenberg
IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart.
Journal of molecular and cellular cardiology 2005;38(3):505-15.
2003: Neil Sawhney; Alborz Hassankhani; Barry H Greenberg
Calcific aortic stenosis in the elderly: a brief overview.
The American journal of geriatric cardiology 2003;12(3):178-82.
2002: JianFeng Peng; Devorah Gurantz; Van Tran; Randy T Cowling; Barry H Greenberg
Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis.
Circulation research 2002;91(12):1119-26.
2002: Randy T Cowling; Devorah Gurantz; JianFeng Peng; Wolfgang H Dillmann; Barry H Greenberg
Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-alpha or interleukin-1 beta.
The Journal of biological chemistry 2002;277(8):5719-24.
1999: Devorah Gurantz; Randy T Cowling; F J Villarreal; Barry H Greenberg
Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts.
Circulation research 1999;85(3):272-9.
1998: Jay N Cohn; S O Goldstein; Barry H Greenberg; B H Lorell; Robert Bourge; Brian E Jaski; S O Gottlieb; Frank A McGrew; David L DeMets; B G White
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.
The New England journal of medicine 1998;339(25):1810-6.